BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22095184)

  • 1. Etanercept induced hidradenitis suppurativa.
    Pellegrino M; Taddeucci P; Peccianti C; Mei S; Fioravanti A; Fimiani M
    G Ital Dermatol Venereol; 2011 Dec; 146(6):503-4. PubMed ID: 22095184
    [No Abstract]   [Full Text] [Related]  

  • 2. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ; Pelekanou E; Antonopoulou A; Petropoulou H; Baziaka F; Karagianni V; Stavrianeas N; Giamarellou H
    Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Candida chorioretinitis following etanercept treatment for hidradenitis suppurativa.
    Arriola-Villalobos P; Díaz-Valle D; Alejandre-Alba N; López-Abad C; Méndez-Fernández R; Benítez-del-Castillo JM
    Eye (Lond); 2008 Apr; 22(4):599-600. PubMed ID: 18239677
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept for the treatment of hidradenitis suppurativa.
    Sotiriou E; Apalla Z; Ioannidos D
    Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548
    [No Abstract]   [Full Text] [Related]  

  • 6. Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept.
    Henderson RL
    J Drugs Dermatol; 2006; 5(10):1010-1. PubMed ID: 17373153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of etanercept in hidradenitis suppurativa.
    Zangrilli A; Esposito M; Mio G; Mazzotta A; Chimenti S
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1260-2. PubMed ID: 18331322
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute injection site reaction to intraarticular etanercept administration.
    Arnold EL; Khanna D; Paulus H; Goodman MP
    Arthritis Rheum; 2003 Jul; 48(7):2078-9. PubMed ID: 12847708
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept-induced granulomas: comment on the article by Phillips and Weinblatt.
    Hübscher O
    Arthritis Rheum; 2006 Apr; 55(2):340; author reply 340-1. PubMed ID: 16583387
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Acta Derm Venereol; 2008; 88(3):281-2. PubMed ID: 18480934
    [No Abstract]   [Full Text] [Related]  

  • 11. Lichen planus associated with etanercept.
    Battistella M; Rivet J; Bachelez H; Lioté F
    Br J Dermatol; 2008 Jan; 158(1):188-90. PubMed ID: 17944978
    [No Abstract]   [Full Text] [Related]  

  • 12. Granulomatous lung disease occurring during etanercept treatment.
    Phillips K; Weinblatt M
    Arthritis Rheum; 2005 Aug; 53(4):618-20. PubMed ID: 16082636
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
    Lai-Cheong J; Warren R; Bucknall R; Parslew R
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis.
    Sterba G; Sterba Y; Stempel C; Blank J; Azor E; Gomez L
    Isr Med Assoc J; 2010 Jul; 12(7):443-5. PubMed ID: 20862830
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of sarcoidosis during etanercept therapy.
    González-López MA; Blanco R; González-Vela MC; Fernández-Llaca H; Rodríguez-Valverde V
    Arthritis Rheum; 2006 Oct; 55(5):817-20. PubMed ID: 17013853
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myelogenous leukaemia following etanercept therapy.
    Bakland G; Nossent H
    Rheumatology (Oxford); 2003 Jul; 42(7):900-1. PubMed ID: 12826706
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary rheumatoid nodules in an etanercept-treated patient.
    Hübscher O; Re R; Iotti R
    Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hidradenitis suppurativa with etanercept injection.
    Adams DR; Yankura JA; Fogelberg AC; Anderson BE
    Arch Dermatol; 2010 May; 146(5):501-4. PubMed ID: 20479297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation syndrome after etanercept treatment.
    Sandhu C; Chesney A; Piliotis E; Buckstein R; Koren S
    J Rheumatol; 2007 Jan; 34(1):241-2. PubMed ID: 17216706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.